- https://www.novartis.com/news/blood-cancer-awareness-month-cutting-edge-innovation-hematology
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
- https://www.novartis.com/news/beyond-pill-precision-medicine-practice
Learn how we are shifting from making the patient fit the treatment to making the treatment fit the patient.
- https://www.novartis.com/news/improving-diabetes-awareness-and-treatment-adherence-india
Through a successful patient support program, Novartis is taking diabetes care beyond the pill in India.
- https://www.novartis.com/news/how-digital-technologies-are-creating-new-normal-people-living-copd
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
- https://www.novartis.com/news/when-innovation-draws-new-future-patient-treatments
A recent summit explored how technological advances could impact patient care.
- https://www.novartis.com/news/taking-action-psoriasis-patients-who-psoriasis-resolution
The World Health Organization (WHO) passed a resolution on psoriasis that creates an urgent call to action for the international community.
- https://www.novartis.com/news/novartis-medikidz-and-copd-foundation-partnership-superhero-proportions
We teamed up with Medikidz and the COPD Foundation to develop a creative way to explain COPD to children.
- https://www.novartis.com/news/innovation-practice-how-we-form-partnerships-pharma
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
- https://www.novartis.com/news/novartis-evolving-business-practices-better-educate-medical-community
Seeking to evolve the way it educates and engages with healthcare professionals, Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.
- https://www.novartis.com/news/medical-researchers-using-new-tools-turn-science-fiction-science-fact
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
Pagination
- ‹ Previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- 19
- › Next page